![](http://investorshub.advfn.com/images/default_ih_profile2_4848.jpg?cb=0)
Thursday, May 14, 2020 7:53:59 AM
1) B has no effect on covid during these in-vitro studies. IPIX is bankrupt and trades below a nickel, if that.
2) B has some mild positive effect on covid, but not enough to warrant further studies or attract interest from larger pharmaceutical companies. IPIX is bankrupt and trades between a nickel and a dime. A minuscule chance exists that another company acquires the rights to B for one of its original purposes based on data garnered from the RBL studies. B has experienced this scenario already with meeting its phase 2 goals for trials with OM but with not good enough results to attract funding for a phase 3 trial.
3) B has a statistically significant effect on covid and advances into human trials. IPIX is still bankrupt so a larger pharma company partners with IPIX for a majority control of revenue from B if it succeeds, or a few potential partners lie in wait for the human trial results, or someone just buys it outright. IPIX likely trades between .25 and 1.00.
If there is good news, the PR will most likely be released before 830am on that day (most covid-related companies seem to be putting them out around 7am or as early as possible). Bad news will come right at 930am or just after the bell.
It’s important to realize this stock is a lottery ticket and we’re all hoping for scenario 3. Scenario 2 and 1 are most likely (as they are with most clinical stage biooharma drugs - most fail) but scenario 3 means a promising drug for covid patients and $ for shareholders.
Recent IPIX News
- Form 8-K - Current report • Edgar (US Regulatory) • 02/01/2024 01:30:25 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 12/05/2023 09:25:58 PM
- Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/20/2023 09:05:44 PM
- Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSB • Edgar (US Regulatory) • 11/15/2023 01:00:19 PM
- Form 8-K - Current report • Edgar (US Regulatory) • 10/30/2023 08:15:25 PM
- Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/28/2023 01:00:08 PM
Maybacks Global and Inventel Products To Launch Global 24 Hour Shopping Channel • AHRO • Sep 3, 2024 9:15 AM
UC Asset announces plan of management stock buyback • UCASU • Sep 3, 2024 9:00 AM
Element79 Gold Corp Appoints Warren Levy to Board of Directors • ELMGF • Aug 28, 2024 9:51 AM
Integrated Ventures Announces Strategic Entry Into Health & Wellness Industry with Focus on GLP-1 Products • INTV • Aug 28, 2024 8:30 AM
ELEMENT79 ANNOUNCES UPLISTING TO OTCQB VENTURE MARKET • ELMGF • Aug 26, 2024 10:03 AM
North Bay Resources Announces Gold Assays up to 2.2 Ounces per Ton, Fran Gold Project, British Columbia • NBRI • Aug 26, 2024 10:00 AM